Clinical Research Directory
Browse clinical research sites, groups, and studies.
Combination Therapy for Warts: Candida Antigen vs. Topical Keratolytic
Sponsor: Benha University
Summary
Objective: To compare the efficacy, safety, and recurrence rates of topical salicylic acid/lactic acid (SA/LA) monotherapy (Group A), intralesional Candida antigen (CA) monotherapy (Group B), and their combination (Group C) for the treatment of warts.
Official title: Comparative Efficacy of Topical Salicylic Acid/Lactic Acid, Intralesional Candida Antigen, and Their Combination in the Treatment of Warts: A Randomized, Assessor-Blinded, Controlled Trial
Key Details
Gender
All
Age Range
5 Years - 60 Years
Study Type
INTERVENTIONAL
Enrollment
126
Start Date
2023-12-01
Completion Date
2024-12-30
Last Updated
2026-08-04
Healthy Volunteers
No
Conditions
Interventions
Salicylic Acid/Lactic Acid Topical Solution
Patients receive topical application of Salicylic Acid 40% and Lactic Acid 16% once daily for up to 6 weeks.
Candida Antigen Intralesional Injection
Patients receive intralesional injection of Candida Antigen (0.1-0.3 mL) every 2 weeks for up to 6 sessions.
Candida Antigen and Salicylic Acid/Lactic Acid
Patients receive intralesional injection of Candida Antigen (0.1-0.3 mL) every 2 weeks for up to 6 sessions, with topical Salicylic Acid 40% and Lactic Acid 16% applied in between.
Locations (1)
Outpatient Clinic of Dermatology, Venereology and Andrology Department at Benha University Hospitals
Banhā, Qalyubia Governorate, Egypt